Travere Therapeutics, Inc. (TVTX)

NASDAQ: TVTX · IEX Real-Time Price · USD

5.26

-0.13 (-2.41%)

At close: Apr 26, 2024, 4:00 PM

5.36

+0.10 (1.90%)

After-hours: Apr 26, 2024, 4:32 PM EDT

Travere Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2012
Cash & Equivalents	58.18	61.69	165.75	84.77	62.44	102.87	99.39	41	37.81	18.2	Upgrade
Short-Term Investments	508.68	388.56	387.13	276.82	336.09	368.67	201.24	261.72	238.65	9.56	Upgrade
Cash & Cash Equivalents	566.85	450.25	552.88	361.59	398.52	471.54	300.63	302.72	276.45	27.76	Upgrade
Cash Growth	25.90%	-18.56%	52.90%	-9.27%	-15.48%	56.85%	-0.69%	9.50%	895.87%	349.90%	Upgrade
Receivables	21.18	16.65	15.91	15.93	18.05	12.66	13.87	18.51	12.46	7.96	Upgrade
Inventory	40.9	4.52	7.31	7.61	6.08	5.62	5.35	2.83	2.54	0.8	Upgrade
Other Current Assets	-12.16	15.02	6.72	25.29	6.41	5.86	5.95	8.29	10.49	0.81	Upgrade
Total Current Assets	616.78	486.44	582.83	410.41	429.06	495.68	325.81	332.35	301.93	37.33	Upgrade
Property, Plant & Equipment	25.54	30.05	34.3	35.09	2.89	3.15	3.23	2.59	0.43	0.67	Upgrade
Long-Term Investments	0	0	0	0	0	15	0	0	45.57	0	Upgrade
Goodwill and Intangibles	104.44	97.07	148.44	154.13	158.14	187.63	185.75	182.98	162.47	95.2	Upgrade
Other Long-Term Assets	42.16	59.03	11.07	7.81	14.71	7.71	5.56	7.36	1.86	2.27	Upgrade
Total Long-Term Assets	172.14	186.15	193.81	197.03	175.74	213.48	194.54	192.93	210.33	98.14	Upgrade
Total Assets	788.91	672.59	776.63	607.44	604.8	709.16	520.35	525.28	512.26	135.47	Upgrade
Accounts Payable	41.68	17.29	15.14	12.13	26.61	6.95	18.94	7.52	7.64	7.12	Upgrade
Deferred Revenue	8.93	22.91	36.65	0	0	0	0	0	0	0	Upgrade
Current Debt	4.91	4.43	3.91	0.36	0	22.46	0	0	0	40.49	Upgrade
Other Current Liabilities	122.39	97.53	68.39	80.17	68.84	75.21	66.73	75.74	79.34	59.93	Upgrade
Total Current Liabilities	177.91	142.16	124.09	92.66	95.45	104.62	85.67	83.26	86.98	107.54	Upgrade
Long-Term Debt	399.88	403.06	258.08	243.68	204.86	195.09	45.08	44.42	43.77	43.29	Upgrade
Other Long-Term Liabilities	10.32	84.52	92.36	59.89	83.29	91.2	96.47	89.83	81.55	21.9	Upgrade
Total Long-Term Liabilities	410.2	487.57	350.43	303.57	288.16	286.29	141.54	134.25	125.31	65.18	Upgrade
Total Liabilities	588.1	629.73	474.52	396.23	383.6	390.91	227.21	217.52	212.29	172.72	Upgrade
Total Debt	404.78	407.49	261.99	244.03	204.86	217.55	45.08	44.42	43.77	83.77	Upgrade
Debt Growth	-0.66%	55.54%	7.36%	19.12%	-5.83%	382.61%	1.47%	1.50%	-47.76%	5646.21%	Upgrade
Retained Earnings	-1,125.62	-1,014.22	-765.97	-585.88	-416.44	-270.02	-177.66	-113.06	-65.15	-179.18	Upgrade
Comprehensive Income	-1.46	-2.91	-0.56	-0.9	0.73	-1.53	-1.02	-0.49	-0.68	4.29	Upgrade
Shareholders' Equity	200.81	42.85	302.11	211.21	221.2	318.25	293.13	307.77	299.97	-37.25	Upgrade
Net Cash / Debt	162.07	42.76	290.9	117.56	193.66	253.99	255.55	258.3	232.69	-56.01	Upgrade
Net Cash / Debt Growth	279.04%	-85.30%	147.45%	-39.30%	-23.75%	-0.61%	-1.06%	11.01%	-	-	Upgrade
Net Cash Per Share	2.18	0.67	4.86	2.47	4.57	6.28	6.59	6.75	6.19	-2.24	Upgrade
Working Capital	438.87	344.27	458.74	317.75	333.62	391.06	240.14	249.09	214.95	-70.21	Upgrade
Book Value Per Share	2.70	0.67	5.05	4.44	5.22	7.87	7.56	8.32	8.94	-1.49	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).